Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

A highly effective class of weight loss drug has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound ...

With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Rival manufacturers fight for the right to sell weight loss drugsThere’s a new fight brewing between ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...

If you or someone you know has diabetes, you’ve likely heard of metformin, a drug that’s primarily prescribed to support ...